Bullfrog AI Holdings Inc. (BFRG): Price and Financial Metrics

Bullfrog AI Holdings Inc. (BFRG): $1.77

0.05 (-2.48%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

F

Add BFRG to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#338 of 347

in industry

BFRG Price/Volume Stats

Current price $1.77 52-week high $8.35
Prev. close $1.82 52-week low $1.74
Day low $1.74 Volume 48,753
Day high $1.92 Avg. volume 1,420,189
50-day MA $2.81 Dividend yield N/A
200-day MA $3.30 Market Cap 13.90M

BFRG Stock Price Chart Interactive Chart >



BFRG Latest News Stream


Event/Time News Detail
Loading, please wait...

BFRG Latest Social Stream


Loading social stream, please wait...

View Full BFRG Social Stream

Latest BFRG News From Around the Web

Below are the latest news stories about BULLFROG AI HOLDINGS INC that investors may wish to consider to help them evaluate BFRG as an investment opportunity.

ASP Isotopes and Bullfrog AI Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / October 27, 2023 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG)(NASDAQ:BFRGW) on The RedChip Small Stocks Big Money® Show, a sponsored program on ...

Yahoo | October 27, 2023

BullFrog AI to Present at Benzinga All Access Event on October 20

GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that Vin Singh, Founder and CEO of BullFrog AI, will present during Benzinga's All Access investor event on Friday, October 20, 2023, at 11:00 a.m. ET. Webcast: https://www.yo

Yahoo | October 18, 2023

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

Discoveries generated by analyzing The Cancer Genome Atlas using proprietary bfLEAP™ platform Target validation will be conducted through partnership with J. Craig Venter Institute (JCVI), a world-leading institution in genomics research and innovation GAITHERSBURG, Md., Oct. 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable

Yahoo | October 5, 2023

BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma

BullFrog AI’s Patented Drug BF-223 Demonstrates Anti-Cancer Activity Against Glioblastoma in Established Animal ModelGAITHERSBURG, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced positive data in a preclinical study investigating the an

Yahoo | September 26, 2023

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its founder and CEO Vin Singh will give a presentation at BioFuture 2023 (Oct. 4-6, 2023) on the Company’s recent partnerships, revenue and growth strategy, and portfoli

Yahoo | September 25, 2023

Read More 'BFRG' Stories Here

BFRG Price Returns

1-mo -40.60%
3-mo -49.28%
6-mo -36.56%
1-year -50.97%
3-year N/A
5-year N/A
YTD -45.71%
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!